Assessment of therapeutic response in ankylosing spondylitis patients undergoing anti-tumour necrosis factor therapy by whole-body magnetic resonance imaging

Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial

(2011) I.-H. Song et al.   ANNALS OF THE RHEUMATIC DISEASES

A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial

(2010) M. Dougados et al.   ANNALS OF THE RHEUMATIC DISEASES

Spinal inflammation lesions as detected by magnetic resonance imaging in patients with early ankylosing spondylitis are more often observed in posterior structures of the spine

(2010) A. G. Bochkova et al.   RHEUMATOLOGY

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

(2009) M Rudwaleit et al.   ANNALS OF THE RHEUMATIC DISEASES

Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group

(2009) M Rudwaleit et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis

(2009) Nick Barkham et al.   ARTHRITIS AND RHEUMATISM

Whole-body MR imaging for patients with rheumatism

(2009) Sabine Weckbach   EUROPEAN JOURNAL OF RADIOLOGY

Effectiveness, Safety, and Predictors of Good Clinical Response in 1250 Patients Treated with Adalimumab for Active Ankylosing Spondylitis

(2009) M. RUDWALEIT et al.   JOURNAL OF RHEUMATOLOGY

Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis

(2009) B. DIJKMANS et al.   JOURNAL OF RHEUMATOLOGY

Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients

(2009) Zhiming Lin et al.   RHEUMATOLOGY INTERNATIONAL

Systematic assessment of inflammation by magnetic resonance imaging in the posterior elements of the spine in ankylosing spondylitis

(2009) Walter P. Maksymowych et al.   ARTHRITIS CARE & RESEARCH

Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence

(2008) H Marzo-Ortega et al.   ANNALS OF THE RHEUMATIC DISEASES

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial

(2008) D van der Heijde et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period

(2008) Jürgen Braun et al.   ARTHRITIS AND RHEUMATISM

Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years

(2008) A. N. Bennett et al.   ARTHRITIS AND RHEUMATISM

Critical appraisal of assessment of structural damage in ankylosing spondylitis: Implications for treatment outcomes

(2008) Joachim Sieper et al.   ARTHRITIS AND RHEUMATISM

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

(2008) Paul Emery et al.   LANCET